Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132457 · ClinicalTrials.gov registry record · NA
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 1,830
- Enrollment target
NCT00132457: Completed NA study, sponsored by Centers for Disease Control and Prevention.
NCT00132457 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,830 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00132457, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,830 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic. The study design is two randomized trials with enrollment at multiple family planning clinics and sexually transmitted disease (STD) clinics following a common protocol.
Interventions
- PROCEDURE Self-collected vaginal swab for chlamydia testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,830 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00132457 record still lists
NCT00132457 is an interventional study that assigns participants to a tested intervention. Its 1,830 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 1 intervention - of which Self-collected vaginal swab for chlamydia testing is the first listed.
NCT00132457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00132457 about?
NCT00132457 is a clinical study titled "Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection". The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic. The study design is two randomized trials with enrollment at mult...
What is the current status of trial NCT00132457?
This trial is currently completed. It is a NA study. The enrollment target is 1,830 participants. The study started on 2003-10. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00132457?
The interventions under investigation include: Self-collected vaginal swab for chlamydia testing (PROCEDURE).
Who is sponsoring clinical trial NCT00132457?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00132457's enrollment target sits among peer trials
1,830 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia